Home   >  
Microbiology/Virology
  >  
SARS CoV

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

SARS CoV

Chemical Structure Cat. No. Product Name CAS No.
SSAA09E2 Chemical Structure
BCP43791 SSAA09E2 883944-52-3
SSAA09E2 is a novel inhibitor of SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
AT-511 Chemical Structure
BCP43134 AT-511 1998705-64-8
AT-511 is a prodrug form of the antiviral nucleoside analog AT-9010. It reduces the infectious virus yield in cells infected with Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome CoV (SARS-CoV), SARS-CoV-2, human CoV 229E (HCoV-229E), and HCoV-OC43 (EC90s = 37, 0.47, 2.8, 1.2, and 0.5 µM, respectively). AT-527 is the sulfate salt of AT-511.
Oxocarbazate Chemical Structure
BCP42707 Oxocarbazate 1014405-03-8
Oxocarbazate is an inhibitor of human cathepsin L.
Merafloxacin Chemical Structure
BCP42636 Merafloxacin 91188-00-0
Merafloxacin is a fluoroquinolone antibacterial, which was also identified as a −1 PRF inhibitor of SARS-CoV-2.
Decanoyl-arg-val-lys-arg-chloromethylketone Chemical Structure
BCP41990 Decanoyl-arg-val-lys-arg-chloromethylketone 150113-99-8
Decanoyl-RVKR-CMK is a subtilisin/Kex2p-like proprotein convertase inhibitor; blocks activity of all seven convertases (PC1, PC2, PC4, PACE4, PC5, PC7 and furin).
SM-102 Chemical Structure
BCP40910 SM-102 2089251-47-6
SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles which is used in the Moderna COVID-19 vaccine.
PF-07321332 Chemical Structure
BCP40653 PF-07321332 2628280-40-8
PF-07321332 is an orally bioavailable 3C-like protease (3CLPRO) inhibitor.
PF-07304814 Chemical Structure
BCP40548 PF-07304814 2468015-78-1
PF07304814 is a novel phosphate prodrug for PF-00835231,PF-07304814 rapidly undergoes in vivo conversion to the active metabolite PF-00835231.
Anti-SARS-COV2 S1 antibody  EMA006 Chemical Structure
BCP39134 Anti-SARS-COV2 S1 antibody EMA006 ASCSAE
Anti-SARS-COV2 Nucleoprotein antibody C00152 Chemical Structure
BCP39133 Anti-SARS-COV2 Nucleoprotein antibody C00152 ASCNAC2
123下一页末页共 31 条记录 1 / 4 页 
0086-15971444841